Echo Therapeutics Completes Product Development of Prelude SkinPrep System

Echo Therapeutics, Inc., a company developing the needle-free Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude SkinPrep System for transdermal drug delivery, announced Monday that the Company has completed the product development work for its Prelude SkinPrep System and now has the commercially ready product to be used in final clinical trials.
Sun Herald